Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2006

View Archived Issues

XBD-173: clinical anxiolytic effects without benzodiazepine-related adverse events

Phase II evaluation required to establish chemopreventive profile of myoinositol

Sapphire license ghrelin mimetic from Novo Nordisk

Shigamabs shown safe and well tolerated in phase I for E. coli infections

Progenics and Wyeth begin pivotal trials with POI drug candidate

AEterna Zentaris reports new company focus

Somanta and University of Bradford's ICT sign cancer research alliance

StemCells' neural stem cell product enters phase I for Batten disease

ChemGenex begins advanced clinical trials of Ceflatonin for CML

Avidia advances novel IL-6 inhibitor to phase I for Crohn's disease

Access advances towards commercialization of MuGard for oral mucositis

BioDelivery Science expects BEMA-fentanyl NDA filing in Q2 2007

Hospira to acquire Mayne

Endpoints not met in phase II trial with Nucryst's topical cream

Novel agents for treating seizures disclosed in recent Lundbeck patent

Recent Millenia Hope patent reports novel HIV-1 RNase H inhibitors

Novel treatment option for lipoprotein disorders jointly reported by Negma-Lerads and CNRS

Noxafil recommended for approval in Europe

Exenatide gains positive European opinion for the treatment of type 2 diabetes

Merck announces acquisition of Serono

Bionomics reports on novel inhibitors of Kv1.3 for the treatment of multiple sclerosis

Adjunctive estrogen therapy in women with schizophrenia enters phase II study: News in Context

Neurogen and Merck's novel TRPV1 antagonist presented at the ACS meeting

GSK reports on new MCHR1 antagonists for the treatment of obesity

Potent efficacy in vivo of Merck's novel glucagon receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...